Eden Research Licence Agreement

Created on 06.06.13

Eden Research has announced an agreement with Neo-Pharma Innovations to develop their terpene-based head lice treatment for commercial sale.

The agreement, announced on June 05, grants Neo-Pharma a 20-year licence to the intellectual property rights to the treatment, allowing them to seek regulatory approval, manufacture and sell the product globally.


Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved